Back to Trials
NCT06941324NARecruiting

Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors

University of Michigan Rogel Cancer Center

Start Date

6/23/2025

Completion Date

7/1/2028

Summary

This clinical trial evaluates the how well a virtually delivered solution-focused brief therapy (SFBT-C) works to decrease adolescent and young adult cancer survivors' psychological distress in comparison to enhanced treatment-as-usual care. Cancer and its treatment can have immediate and long-term impacts on adolescent and young adult cancer survivor's lives, including education and employment, financial stability, sexual health, and social, romantic, and family relationships. Consequently, many adolescent and young adult cancer survivors report psychological distress, often manifesting as depression and anxiety, and may benefit from psychotherapy to improve their engagement with medical treatment and overall quality of life. SFBT-C is a theory-driven and brief hope-based psychotherapy designed for the unique psychosocial needs facing adolescent and young adult cancer survivors. Undergoing SFBT-C may work better than treatment-as-usual care for the support of psychological distress in adolescent and young adult cancer survivors.

Detailed Description

07JUL2026- Amendment approved updating the study PI to Dr. Sunnye Mayes.

Eligibility Criteria

Age Range: 15 years to 39 years

Inclusion Criteria: * 15 - 39 years old * Diagnosed with cancer * Receiving active cancer care (6 weeks post initial diagnosis to control for emotional responses to normative stressors) or within 5 years of post-treatment survivorship * Experiencing psychological distress (i.e., a t-score \>= 57 on the Brief Symptom Inventory - 18 items \[BSI-18\]) * Fluent in English Exclusion Criteria: * End-of-life care * \> 5 years into the post-treatment survivorship * Major physical challenges (e.g., hearing loss, developmental delay) * Acute mental health conditions (e.g., active psychosis, suicide risk) * Receiving or newly initiated psychotherapy for psychological distress during the study period

Interventions

BEHAVIORAL

Behavioral Intervention

OTHER

Best Practice

OTHER

Communication Intervention

OTHER

Discussion

OTHER

Health Promotion and Education

OTHER

Health Promotion and Education

OTHER

Interview

OTHER

Questionnaire Administration

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Locations

University of Michigan Comprehensive Cancer Center

Ann Arbor, Michigan 48109

United States